Institute of Hematology and Transfusiology

Warsaw 02-776

0 studies enrolling now · 1 studies all time

What they study most

Secondary Acute Myeloid Leukemia (Secondary AML, sAML)

Studies at this site

• Phase III Randomized Study of Amonafide (AS1413) and Cytarabine Versus Daunorubicin and Cytarabine in Patients With Secondary Acute Myeloid Leukemia (AML)- the ACCEDE Study — Status unconfirmed